Influence of genetic polymorphisms on antidepressant response or maintenance dose in Japanese individuals with depression
| Project/Area Number |
25460191
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | University of Shizuoka |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 抗うつ薬 / 維持量 / うつ病 / 遺伝子多型 / 応答性 / 維持服用量 / 1抗うつ薬 |
|---|
| Outline of Final Research Achievements |
This study was conducted to examine genetic polymorphisms associated with antidepressant response or maintenance dose setting for antidepressant therapy in Japanese individuals with depression. I assessed antidepressant response using antidepressant cessation by exacerbation or control of depressive symptoms. In addition, I calculated the maintenance dose using the imipramine equivalent scale. I found that the presence of CREB1 rs4675690 polymorphism may be associated with the response to selective serotonin-reuptake inhibitors; in addition, the concomitant diazepam equivalent dose and the presence of the CREB1 rs4675690 polymorphism were associated with antidepressant maintenance doses.
|
Report
(4 results)
Research Products
(5 results)
